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The risk to patients and healthcare workers of resuming elective orthopaedic surgery 
following the peak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
pandemic has been difficult to quantify. This has prompted governing bodies to adopt a 
cautious approach that may be impractical and financially unsustainable. The lack of 
evidence has made it impossible for surgeons to give patients an informed perspective of 
the consequences of elective surgery in the presence of SARS-CoV-2. This study aims to 
determine, for United Kingdom population, the probability of a patient being admitted 
with an undetected SARS-CoV-2 infection and their resulting risk of death; taking into 
consideration the current disease prevalence, reverse transcription-polymerase chain 
reaction (RT-PCR) testing and preassessment pathway. 
Methods 
The probability of SARS-CoV-2 infection with a false-negative test was calculated using a 
lower-end RT-PCR sensitivity of 71%, specificity of 95% and the UK disease prevalence 
of 0.24% reported in May 2020. Subsequently, a case fatality rate of 20.5% was applied as 
a worst-case scenario. 
Results 
The probability of SARS-CoV-2 infection with a false-negative preoperative test was 
0.07% (around 1 in 1,400). The risk of a patient with an undetected infection being 
admitted for surgery and subsequently dying from COVID-19 is estimated at roughly 1 in 
7,000. However, if an estimate of the current global infection fatality rate (1.04%) is 
applied, the risk of death would be around 1 in 140,000, at most. This calculation does not 
take into account the risk of nosocomial infection. Conversely, it does not factor in that 
patients will also be clinically assessed and asked to self-isolate prior to surgery. 
Conclusion 
Our estimation suggests that the risk of patients being inadvertently admitted with an 
undetected SARS-CoV-2 infection for elective orthopaedic surgery is relatively low. 
Accordingly, the risk of death following elective orthopaedic surgery is low, even when 
applying the worst case fatality rate. 
 
Take home message 
- In May 2020, the probability of admitting a patient for elective orthopaedic surgery with 
SARS-CoV-2 infection and a false-negative preoperative test was 0.07% (around 1 in 
1,400). 
- The probability of admitting a false-negative patient for elective orthopaedic surgery can 
be recalculated at any time using the estimated background prevalence in the community 
  
Introduction 
The incidence of COVID-19 cases in the United Kingdom is sharply decreasing.[[1]] 
Planning to recover surgical services must balance the risks of infection with the 
requirement for elective surgery in order to reduce the impact on patients’ outcomes and 
quality of life.[[2,3]] Reviewing the available evidence from the peak of the pandemic is 
discouraging. 
 A mortality rate of 20.5% was reported in a group of 34 elective surgical patients 
who developed COVID-19 after being inadvertently admitted during the early stages of 
the crisis in Wuhan, China. Only seven of the 34 patients underwent orthopaedic 
procedures, two of the orthopaedic patients required admission to the intensive care unit 
and subsequently died.[[4]] Recently, the multicentre international COVIDSurg cohort 
study reported a mortality rate of 18.9% in a group of 280 patients who acquired 
perioperative COVID-19 infection during admission for elective surgery. The 24 
contributing countries employed a pragmatic approach to COVID-19 diagnosis, using a 
combination of polymerase chain reaction (PCR) (85%), radiological (7.1%), and clinical 
(6.0%) findings, depending on the resources available in each centre.[[5]] Both studies 
reported on a highly heterogeneous sample of patients, including, but not limited to cancer 
sufferers.[[4,5]] 
 These findings suggest resumption of elective orthopaedics may have a significant 
mortality risk, however the patients included in these studies received care early in the 
pandemic within centres across several countries, with no predefined or standardized 
preoperative testing or risk stratification strategy, at a time when treatment protocols were 
rapidly evolving. These figures are taken from a period around the peak of the pandemic 
and will be less relevant as we approach the end of the current COVID-19 crisis.  
Screening preoperative patients: Reverse transcription-polymerase chain reaction (RT-
PCR) 
 In order to resume elective orthopaedic surgery, the British Orthopaedic Association 
(BOA) and NHS England recommend preoperative testing of patients,[[6,7]] however, the 
sensitivity of the swab test is thought to be between 71% to 98%, meaning up to 29% of 
infected patients could falsely test negative.[[8]] The specificity has been estimated to be 
over 95%.[[9]] Early epidemiological studies suggest that 5% to 80% of severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are asymptomatic at any 
given time.[[10]] In one sero-epidemiological study conducted in the German county of 
Heinsberg the asymptomatic rate was found to be 22.2%.[[11]] In Iceland, where 
widespread screening has been employed, only 57% of the individuals who tested positive 
reported symptoms.[[12]] These findings suggest asymptomatic, pre-symptomatic or sub-
clinical patients may evade simple symptom screening and present a risk of transmission 
to other patients and staff. 
Prevalence of the disease in the community 
Arguably, the most important risk factor for SARS-CoV-2 infection is the prevalence in 
the community; as well as its infectivity and, thereby, the incidence of new cases. Due to a 
mismatch between the testing resources available and the actual number of active cases 
this is difficult to calculate with certainty. Estimations can, however, be made based on the 
most recent, representative UK population surveys. The UK Office for National Statistics 
(ONS) estimated the prevalence of SARS-CoV-2 infection during the period of the 11th 
May to the 24th May 2020 was 0.24% (95% confidence interval (CI) 0.11% to 0.46%). 
This was based on random sampling of 18,913 individuals within the community 
(excluding hospital, care home, and institutional settings). During the same time period the 
weekly incidence has been estimated to be 0.11% (95% CI 0.06% to 0.16%).[[13]] 
Prevalence amongst healthcare workers  
Healthcare workers (HCWs) have a higher prevalence of SARS-CoV-2 infection than the 
rest of the population; the latest figures from May 2020 show that the prevalence in 
individuals working in patient-facing healthcare was 1.73%.[[13]] A study by the 
University of Cambridge found that in a sample of 1,032 asymptomatic staff, 31 tested 
positive (3%), only 17 of whom remained truly asymptomatic (1.6%).[[14]] This is 
relevant when assessing risk of hospital staff to patient transmission. 
 We aim to use the most up-to-date data to estimate the risk of patients being 
admitted for an elective orthopaedic procedure with an undetected SARS-CoV-2 infection 
and subsequently dying from COVID-19. 
Methods 
Calculating the risk of missed SARS-CoV-2 infection in elective orthopaedic patients 
using pre-test probability 
 Given the reportedly low sensitivity of the PCR test, interpretation of a result will 
depend not only on the accuracy of the test itself but also on the pre-test probability of the 
patient having a disease. Clinicians regularly apply the concept of calculating pre-test 
probabilities in day-to-day practice; this could be derived from hard data such as disease 
prevalence. Alternatively, clinicians can use their experience to estimate pre-test 
probabilities based on their interpretation of symptoms, history of exposure, blood tests, 
and radiological imaging.[[15]] Once a pre-test probability is determined, the risk of a 
missed infection can then be calculated using Bayes’ theorem.[[16]] This is described as 
the probability of an event, based on prior knowledge of conditions that might be related 
to the event.[[17]]  
 Due to the serious nature of the disease and lack of a validated method of 
quantifying and incorporating the effect of the above influencing factors we decided to 
include the only quantifiable risk factor (disease prevalence) in our calculation. This may 
lead to over-estimation of the pre-test probability of being infected and would present the 
possible worst-case scenario. 
Calculating risk of death  
Risk of death from a viral infection within a population can be estimated by the case 
fatality rate (CFR), which is the number of deaths per number of reported cases, or by the 
infection fatality rate (IFR), which is an estimate of the fatality rate in all patients with the 
disease, including those who are asymptomatic or have not been tested. During pandemics, 
evaluating these figures can be a hazardous exercise.[[18,19]] During the 2009 ‘swine flu’ 
(H1N1 influenza) outbreak the reported CFR was 0.1% to 5.1%. Subsequently the World 
Health Organization reported that ‘swine flu’ ended up with an IFR of 0.02%, five times 
lower than the lowest CFR estimates during the original outbreak. Therefore, it is 
important to acknowledge that during a pandemic the IFR could potentially decrease five- 
to ten-fold following final reporting.[[20]] Current data from multiple sources report a 
CFR for COVID-19 to be between 0.56% to 14%[[1,20-24]] and estimations for the IFR 
range between 0.3% and 1.3% (Table I).[[11,20,23-26]] 
 
Table I. Reported case fatality rates and estimated infection fatality rate worldwide. 
Region/case study CFR, % IFR, % 
Global 6.3[[21]] 0.38[[20]] to 
1.04[[25]] 
China 1.38[[24]] to 2.3[[22]] 0.66[[24]] 
UK 14[[21]] 0.9[[26]] 
Germany 4.7[[21]] 0.36[[11]]* 
Iceland 0.56[[20]] 0.3 to 0.56[[20]] 
Diamond Princess cruise 
ship 
2.6[[23]] 1.3[[23]] 
H1N1 outbreak 2009 - for 
comparison 
0.1 to 5.1[[20]] 0.02[[20]] 
*Specific to Gangelt, County of Heinsberg. 
CFR, case fatality rate; H1N1, swine flu; IFR, infection fatality rate. 
 
 
 Although wide-ranging CFR estimates are available, it must be noted that patients 
face the additional risk of undergoing surgery. Therefore, to estimate the risk of mortality 
in the elective orthopaedic cohort of patients, a worst-case scenario should be adopted. We 
decided to base our calculation on the CFR reported in elective surgical patients in Wuhan, 
China (20.5%),[[4]] which is even higher than the CFR in the recent COVIDSurg report 
(18.9%).[[5]] 
Results 
Using the available data of prevalence within the community (0.24%)[[13]] to determine 
the predicted pre-test probability and matching this to the sensitivity and specificity of the 
SARS-CoV-2 swab test used, the chance of any given patient being admitted for surgery 
with a false negative result is 0.07%, or around 1 in 1,400. However, it must be noted that 
this calculation does not take into account the risk of acquiring COVID-19 perioperatively. 
Equally it does not factor in the relative risk reduction from choosing asymptomatic 
patients who have been risk stratified, self-isolated and thoroughly pre-assessed by the 
multidisciplinary team. 
 The above calculations are based on the estimated disease prevalence in early May 
2020 in England and Wales.[[13]] Examples for different levels of prevalence are included 
below for reference (Table II). Clearly surgeons must be vigilant in interpreting the risks 
of viral infection with changing prevalence. 
 
Table II. Varying positive predictive value and negative predictive value of severe acute 
respiratory syndrome coronavirus 2 swab depending on prevalence in population – 
calculated using a reverse transcription-polymerase chain reaction sensitivity of 71%. 














3.00* 31 69 0.94 0.90 
1.00 13 42 0.31 0.30 
0.50 6.7 26 0.15 0.15 
0.24† 3.3 15 0.07 0.07 
0.13‡ 1.8 8.5 0.04 0.04 
0.05 0.71 3.4  0.02 0.01 
*With a 3.00% prevalence, using a test-specificity of 95%, for every 100 people who test 
positive only 31 actually have the disease. When a test-specificity of 99% is used, for 
every 100 people who test positive only 69 have the disease. 
†Example used in the calculation above, using 0.24% prevalence estimated by Office for 
National Statistics (ONS) 28th May 2020.[[13]] 
‡Alternative example using 0.13% prevalence estimated by ONS 5th June 2020.[[9]] 
NPV, negative predictive value; PPV, positive predictive value. 
 
 
 Based upon the worst-case CFR of 20.5% and the calculated risk of 1 in 1,400 pre-
symptomatic false negative patients who undergo surgery developing COVID-19, 
approximately 1 in 7,000 patients undergoing an elective orthopaedic procedure will die of 
the disease.  
 The best-case scenario, however unlikely, is that a patient undergoing elective 
orthopaedic surgery has the same risk of death as a person in the community. If a global 
IFR of 1.04% is employed as per the recent modelling by Grewell and De Leo[[25]] (one 
of the higher values, to be cautious) then 1.04% of the 1 in 1,400 pre-symptomatic, false 
negative patients would die, resulting in a rate of roughly 1 in 140,000 patients undergoing 
elective surgery who will die from COVID-19. 
Discussion 
The aim of this study was to determine the risk of a patient being admitted for elective 
orthopaedic surgery with a missed SARS-CoV-2 infection and their subsequent risk of death. 
The probability of a patient having a SARS-CoV-2 infection despite a negative test was 
estimated as 1 in 1,400. 
 This estimated probability is without calculating the additional positive effect of pre-
operative risk stratification, self-isolation, thorough clinical assessment and implementation 
of several mitigating factors to reduce risk to patients and staff. This analysis may aid 
surgeon to patient discussion preoperatively during the consenting process when resuming 
elective orthopaedic surgery. To provide context to the theoretical risk of death, surgeons can 
also use the background risk of death from an elective orthopaedic procedure for comparison. 
For example, total knee arthroplasty (TKA) has a 30-day mortality of 0.20% (95% CI 0.17% 
to 0.24%) or one in 500; and a 90-day mortality of 0.39% (95% CI 0.32% to 0.49%), roughly 
one in 250.[[27]] In total hip arthroplasty (THA) the 30-day mortality is 0.30% (95% CI 
0.22% to 0.38%) or one in 333; 90-day mortality is 0.65% (95% CI 0.5% to 0.81%) or one in 
153.[[28]] In addition, one should consider the background risk of death from any cause, for 
example recent age-standardized mortality rate data from England and Wales shows an 
average 65- to 69-year-old male has a 1.46% risk of death annually, or one in 68. For females 
of the same age group this is 0.94%.[[29]] The risks from elective surgery and COVID-19 
will be cumulative, nonetheless this will be smaller than the already present, but arguably 
small, background risk of death from all causes in a given year. 
 The calculations made thus far have also not taken account of the additional risk of 
nosocomial SARS-CoV-2 infection acquired from healthcare staff during the hospital 
admission. This has the potential to be the biggest risk to the patient given the higher 
prevalence amongst HCWs. Each additional interaction with a member of the healthcare team 
may potentially present a further risk, which is determined not only by the prevalence within 
HCWs but also the transmission rate. Although the Cambridge study reported a high 
prevalence among HCWs (3%), only seven out of 520 (1.34%) staff working in ‘green zones’ 
were both asymptomatic and test-positive. ‘Green zones’ were defined as ‘clinical areas 
without any known or suspected COVID-19 cases’. This illustrates that prevalence is not 
uniform across all hospital working zones. Furthermore, this study was conducted in April 
2020 when the prevalence was high. 
 Transmission rates between patient-to-patient, staff-to-patient, and vice-versa are 
difficult to calculate. R0 is the basic reproductive number, which measures the infectiousness 
of a disease if left to spread. R0 is a static number, whereas Rt (alternatively known as Re or 
R-effective) is more relevant in a hospital setting as it represents the actual transmission rate 
at a given time and reflects changes in infectiousness of the virus in response to social 
distancing measures, mask usage[[30]] and increases in the number of immune HCWs.[[31]] 
Hospital workers may be less susceptible as suggested in a recent study conducted in New 
York which found 36% of staff had developed antibodies in one hospital.[[32]] Rt can be 
further reduced by introducing green pathways with stricter policies[[6]] than those in the 
‘green zones’ previously described. This is supported by evidence from a 2010 Cochrane 
review which showed that the combination of multiple interventions such as hand washing, 
masks, gloves, and gown use can reduce the risk of transmission of respiratory viral illness by 
an odds ratio of 0.09 (95% CI 0.02 to 0.35).[[33]] 
 In our example, the worst mortality figures available for elective surgical patients 
were used to give a cautious estimate of the likelihood of an asymptomatic, false-negative 
testing patient being admitted for surgery and subsequently the risk of dying from COVID-
19. This figure (20.5%) is around 20 times higher than the highest estimates of mortality from 
COVID-19 in the community. This disproportionately high mortality rate cannot be 
explained by the trauma of surgery alone. Likely factors contributing to the high 
complication rate include the underdeveloped patient care protocols and professional learning 
curve faced in dealing with COVID-19 early in the pandemic. The reported sensitivity and 
specificity of RT-PCR is variable, for the calculated risks presented in this study we chose 
the lowest rates to present the worst-case scenario. 
 Our calculations are derived from figures from the most reliable survey study by the 
ONS at the most relevant time to resuming elective surgery. We are aware that prevalence 
and incidence numbers are extremely variable during pandemic. Therefore, it is highly likely 
that the risk may be even further reduced with a reduction in the disease prevalence and 
incidence by the time elective surgery is resumed (Table II). 
 Clinicians need to be aware that, as the prevalence of the disease falls, the positive 
predictive value will decrease leading to patient inconvenience from unnecessary 
cancellations.[[11]] At a prevalence level of 0.24% and swab-test specificity of 95%, for 
every 100 people who test positive, only three will have the disease (Table II). The ONS 
reports that the specificity is likely higher than reported in the literature;[[34]] if a figure 
of 99.9% is used instead, then for every 100 people who test positive, only 63 will have 
the disease.  
 In conclusion, this study provides surgeons with risk estimates of SARS-CoV-2 
infection in UK elective orthopaedic patients. This calculation was dependent on estimated 
disease prevalence in May 2020. It shows that the risk of patients being inadvertently 
admitted with an undetected SARS-CoV-2 infection for elective orthopaedic surgery is 
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